Preliminary experience of adverse drug reactions, tolerability, and efficacy of a once-daily regimen of antiretroviral combination therapy [2]

Journal of Acquired Immune Deficiency Syndromes

Volumn 24, Issue 3, 2000, Pages 287-288

  Hsieh, Szu Min ^a   Hung, Chien Ching ^a   Lu, Po Liang ^b   Chen, Mao Yuan ^a   Chang, Shan Chwen ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

DIDANOSINE; EFAVIRENZ; INDINAVIR; RITONAVIR;

ANTIVIRAL ACTIVITY; COMBINATION CHEMOTHERAPY; DOSE RESPONSE; DRUG EFFICACY; DRUG TOLERABILITY; GASTROINTESTINAL SYMPTOM; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; INSOMNIA; LETTER; MAJOR CLINICAL STUDY; MALAISE; NIGHTMARE; PATIENT COMPLIANCE; PRIORITY JOURNAL; RASH; VERTIGO;

EID: 0034232922     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-200007010-00016     Document Type: Letter

References (4)

1. Adherence: A necessity for successful HIV combination therapy
2. Virological and immunological responses to once-daily dosing of didanosine in combination with stavudine